4/A: MiNK Therapeutics CEO Amends Stock Ownership Filing
Beneficial Ownership Amendment
MiNK Therapeutics CEO Jennifer Buell filed an amended Form 4 to correct a previous filing, disclosing 10,024 shares withheld for tax purposes.
Summary
- An amendment (Form 4/A) was filed by Jennifer Buell, Chief Executive Officer of MiNK Therapeutics, Inc. (INKT).
- The purpose of the amendment is to correct an error in the original Form 4 filed on January 6, 2026.
- The original filing did not include details of 10,024 shares of common stock withheld for payment of withholding taxes.
- This withholding transaction occurred on January 2, 2026, at a price of $11.12 per share.
- Following this reported transaction, Jennifer Buell directly beneficially owns 57,942 shares of MiNK Therapeutics common stock.
Sentiment
Score: 5
Explanation: Neutral. This is a routine administrative correction of a previous filing and does not indicate any positive or negative operational or financial performance.
Future Outlook
NA
Management Comments
- The amendment was filed to correct an error in the original Form 4, which did not include shares withheld for payment of withholding taxes.
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 01/02/2026 | Date of stock issuance and withholding transaction for tax purposes. |
| 01/06/2026 | Date of original Form 4 filing that contained the error. |
| 01/14/2026 | Date of amendment filing (Form 4/A) signature. |
Keywords
MiNK Therapeutics, INKT, Jennifer Buell, Form 4/A, SEC filing, beneficial ownership, stock withholding, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.